Identification of novel matrix metalloproteinase inhibitors by screening of phenol fragments library

Arch Pharm (Weinheim). 2011 Sep;344(9):557-63. doi: 10.1002/ardp.201000350. Epub 2011 Jun 21.

Abstract

In the last 20 years, a great variety of synthetic, low molecular weight MMP inhibitors (MMPIs) have been synthesized and tested, although none has reached clinical utility. Exploration of novel ZBGs and development of non-hydroxamate MMPI has become a focus in current research. It's well-known that polyphenols can produce beneficial effects on human health by their antioxidant properties as well as they have the ability to block gelatinase activity. In this work we tested a series of selected phenols as MMP inhibitors. The most interesting hit (B6) shows sub-micromolar activity against MMP-2 (IC(50) 0.59 ± 0.05 µM, LE = 1.07) and a fairly good selectivity spectrum.

MeSH terms

  • Drug Design*
  • Drug Evaluation, Preclinical
  • Enzyme Inhibitors / pharmacology*
  • Humans
  • Matrix Metalloproteinase Inhibitors*
  • Matrix Metalloproteinases / metabolism
  • Molecular Targeted Therapy*
  • Polyphenols
  • Small Molecule Libraries

Substances

  • Enzyme Inhibitors
  • Matrix Metalloproteinase Inhibitors
  • Polyphenols
  • Small Molecule Libraries
  • Matrix Metalloproteinases